ACR Appropriateness Criteria® on Metastatic Bone Disease

Journal of the American College of Radiology

Volumn 7, Issue 6, 2010, Pages 400-409

  Roberts, Catherine C ^a   Daffner, Richard H ^b   Weissman, Barbara N ^c   Bancroft, Laura ^d   Bennett, D Lee ^e   Blebea, Judy S ^f   Bruno, Michael A ^g   Fries, Ian Blair ^h,i   Germano, Isabelle M ^j,k,l   Holly, Langston ^k,l,m   Jacobson, Jon A ⁿ   Luchs, Jonathan S ^o   Morrison, William B ^p   Olson, Jeffrey J ^k,l,q   Payne, William K ⁱ   Resnik, Charles S ^r   Schweitzer, Mark E ^s   Seeger, Leanne L ^t   Taljanovic, Mihra ^u   Wise, James N ^v   Lutz, Stephen T ^w   more..

^a MAYO CLINIC   (United States)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d FLORIDA HOSPITAL   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^g PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^h Bone Spine and Hand Surgery Chartered   (United States)

ⁱ American Academy of Orthopaedic Surgeons   (United States)

^j MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^k Amer Assoc of Neurol Surgeons   (United States)

^l Congress of Neurological Surgeons ^*  (United States)

^m UCLA MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^o WINTHROP UNIVERSITY HOSPITAL   (United States)

^p THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^q EMORY UNIVERSITY   (United States)

^r UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^s NYU HOSPITAL FOR JOINT DISEASES   (United States)

^t UNIVERSITY OF CALIFORNIA   (United States)

^u UNIVERSITY OF ARIZONA   (United States)

^v UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^w Blanchard Valley Regional Cancer Center   (United States)

more..

Author keywords

bone; imaging; metastatic disease; screening; staging; surveillance

Indexed keywords

TECHNETIUM 99M;

BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; BONE TUMOR; BREAST CANCER; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FRACTURE; HUMAN; IMAGE QUALITY; LONG BONE; LUNG NON SMALL CELL CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; REVIEW; SPINE RADIOGRAPHY; WHOLE BODY SCINTISCANNING; BONE NEOPLASMS; BREAST TUMOR; EVIDENCE BASED MEDICINE; FEMALE; MALE; PATHOLOGY; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROSTATE TUMOR; SECONDARY; STANDARDS; UNITED STATES;

BONE NEOPLASMS; BREAST NEOPLASMS; DIAGNOSTIC IMAGING; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROSTATIC NEOPLASMS; UNITED STATES;

EID: 84928096179     PISSN: 15461440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacr.2010.02.015     Document Type: Review

References (52)

1. Bury T., Barreto A., Daenen F., Barthelemy N., Ghaye B., and Rigo P. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 25 (1998) 1244-1247
2. Gayed I., Vu T., Johnson M., Macapinlac H., and Podoloff D. Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer. Mol Imaging Biol 5 (2003) 26-31
3. Lauenstein T.C., Goehde S.C., Herborn C.U., et al. Whole-body MR imaging: evaluation of patients for metastases. Radiology 233 (2004) 139-148
4. Metser U., Lerman H., Blank A., Lievshitz G., Bokstein F., and Even-Sapir E. Malignant involvement of the spine: assessment by 18F-FDG PET/CT. J Nucl Med 45 (2004) 279-284
5. Schaffer D.L., and Pendergrass H.P. Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate. Radiology 121 (1976) 431-434
6. Algra P.R., Bloem J.L., Tissing H., Falke T.H., Arndt J.W., and Verboom L.J. Detection of vertebral metastases: comparison between MR imaging and bone scintigraphy. Radiographics 11 (1991) 219-232
7. Krishnamurthy G.T., Tubis M., Hiss J., and Blahd W.H. Distribution pattern of metastatic bone disease. A need for total body skeletal image. JAMA 237 (1977) 2504-2506
8. Ludwig H., Kumpan W., and Sinzinger H. Radiography and bone scintigraphy in multiple myeloma: a comparative analysis. Br J Radiol 55 (1982) 173-181
9. Woolfenden J.M., Pitt M.J., Durie B.G., and Moon T.E. Comparison of bone scintigraphy and radiography in multiple myeloma. Radiology 134 (1980) 723-728
10. Parker B.R., Pinckney L., and Etcubanas E. Relative efficacy of radiographic and radionuclide bone surveys in the detection of the skeletal lesions of histiocytosis X. Radiology 134 (1980) 377-380
11. Siddiqui A.R., Tashjian J.H., Lazarus K., Wellman H.N., and Baehner R.L. Nuclear medicine studies in evaluation of skeletal lesions in children with histiocytosis X. Radiology 140 (1981) 787-789
12. Boxer D.I., Todd C.E., Coleman R., and Fogelman I. Bone secondaries in breast cancer: the solitary metastasis. J Nucl Med 30 (1989) 1318-1320
13. Tumeh S.S., Beadle G., and Kaplan W.D. Clinical significance of solitary rib lesions in patients with extraskeletal malignancy. J Nucl Med 26 (1985) 1140-1143
14. Kwai A.H., Stomper P.C., and Kaplan W.D. Clinical significance of isolated scintigraphic sternal lesions in patients with breast cancer. J Nucl Med 29 (1988) 324-328
15. Braunstein E.M., and Kuhns L.R. Computed tomographic demonstration of spinal metastases. Spine 8 (1983) 912-915
16. Smoker W.R., Godersky J.C., Knutzon R.K., Keyes W.D., Norman D., and Bergman W. The role of MR imaging in evaluating metastatic spinal disease. AJR Am J Roentgenol 149 (1987) 1241-1248
17. Even-Sapir E., Martin R.H., Barnes D.C., Pringle C.R., Iles S.E., and Mitchell M.J. Role of SPECT in differentiating malignant from benign lesions in the lower thoracic and lumbar vertebrae. Radiology 187 (1993) 193-198
18. Coleman R.E., Rubens R.D., and Fogelman I. Reappraisal of the baseline bone scan in breast cancer. J Nucl Med 29 (1988) 1045-1049
19. Kunkler I.H., Merrick M.V., and Rodger A. Bone scintigraphy in breast cancer: a nine-year follow-up. Clin Radiol 36 (1985) 279-282
20. Cermik T.F., Mavi A., Basu S., and Alavi A. Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer. Eur J Nucl Med Mol Imaging 35 (2008) 475-483
21. Uematsu T., Kasami M., and Yuen S. Comparison of FDG PET and MRI for evaluating the tumor extent of breast cancer and the impact of FDG PET on the systemic staging and prognosis of patients who are candidates for breast-conserving therapy. Breast Cancer 16 (2009) 97-104
22. Groheux D., Moretti J.L., Baillet G., et al. Effect of (18)F-FDG PET/CT imaging in patients with clinical stage II and III breast cancer. Int J Radiat Oncol Biol Phys 71 (2008) 695-704
23. Iagaru A., Masamed R., Keesara S., and Conti P.S. Breast MRI and 18F FDG PET/CT in the management of breast cancer. Ann Nucl Med 21 (2007) 33-38
24. Kosuda S., Yoshimura I., Aizawa T., et al. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma?. A multicenter retrospective study in Japan. Cancer 94 (2002) 964-972
25. O'Sullivan J.M., Norman A.R., Cook G.J., Fisher C., and Dearnaley D.P. Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital. BJU Int 92 (2003) 685-689
26. Sandblom G., Holmberg L., Damber J.E., et al. Prostate-specific antigen for prostate cancer staging in a population-based register. Scand J Urol Nephrol 36 (2002) 99-105
27. Leibovici D., Spiess P.E., Agarwal P.K., et al. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level. Cancer 109 (2007) 198-204
28. Merrick M.V., and Merrick J.M. Bone scintigraphy in lung cancer: a reappraisal. Br J Radiol 59 (1986) 1185-1194
29. Michel F., Soler M., Imhof E., and Perruchoud A.P. Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning. Thorax 46 (1991) 469-473
30. Erturan S., Yaman M., Aydin G., Uzel I., Musellim B., and Kaynak K. The role of whole-body bone scanning and clinical factors in detecting bone metastases in patients with non-small cell lung cancer. Chest 127 (2005) 449-454
31. Ung Y.C., Maziak D.E., Vanderveen J.A., et al. 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review. J Natl Cancer Inst 99 (2007) 1753-1767
32. Hudson T.M., Chew F.S., and Manaster B.J. Scintigraphy of benign exostoses and exostotic chondrosarcomas. AJR Am J Roentgenol 140 (1983) 581-586
33. Simon M.A., and Kirchner P.T. Scintigraphic evaluation of primary bone tumors. Comparison of technetium-99m phosphonate and gallium citrate imaging. J Bone Joint Surg Am 62 (1980) 758-764
34. Goldstein H., McNeil B.J., Zufall E., Jaffe N., and Treves S. Changing indications for bone scintigraphy in patients with osteosarcoma. Radiology 135 (1980) 177-180
35. McKillop J.H., Etcubanas E., and Goris M.L. The indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients. Cancer 48 (1981) 1133-1138
36. Volker T., Denecke T., Steffen I., et al. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol 25 (2007) 5435-5441
37. Holder L.E. Clinical radionuclide bone imaging. Radiology 176 (1990) 607-614
38. Baur A., Stabler A., Bruning R., et al. Diffusion-weighted MR imaging of bone marrow: differentiation of benign versus pathologic compression fractures. Radiology 207 (1998) 349-356
39. Park S.W., Lee J.H., Ehara S., et al. Single shot fast spin echo diffusion-weighted MR imaging of the spine; is it useful in differentiating malignant metastatic tumor infiltration from benign fracture edema?. Clin Imaging 28 (2004) 102-108
40. Spuentrup E., Buecker A., Adam G., van Vaals J.J., and Guenther R.W. Diffusion-weighted MR imaging for differentiation of benign fracture edema and tumor infiltration of the vertebral body. AJR Am J Roentgenol 176 (2001) 351-358
41. Karchevsky M., Babb J.S., and Schweitzer M.E. Can diffusion-weighted imaging be used to differentiate benign from pathologic fractures?. A meta-analysis. Skeletal Radiol 37 (2008) 791-795
42. Nakanishi K., Kobayashi M., Nakaguchi K., et al. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images. Magn Reson Med Sci 6 (2007) 147-155
43. Ghanem N., Uhl M., Brink I., et al. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol 55 (2005) 41-55
44. Schmidt G.P., Reiser M.F., and Baur-Melnyk A. Whole-body imaging of the musculoskeletal system: the value of MR imaging. Skeletal Radiol 36 (2007) 1109-1119
45. Thomson V., Pialat J.B., Gay F., et al. Whole-body MRI for metastases screening: a preliminary study using 3D VIBE sequences with automatic subtraction between noncontrast and contrast enhanced images. Am J Clin Oncol 31 (2008) 285-292
46. Eustace S., Tello R., DeCarvalho V., et al. A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 169 (1997) 1655-1661
47. Edeiken B., and deSantos L.A. Percutaneous needle biopsy of the irradiated skeleton. Radiology 146 (1983) 653-655
48. El-Khoury G.Y., Terepka R.H., Mickelson M.R., Rainville K.L., and Zaleski M.S. Fine-needle aspiration biopsy of bone. J Bone Joint Surg Am 65 (1983) 522-525
49. Ghelman B., Lospinuso M.F., Levine D.B., O'Leary P.F., and Burke S.W. Percutaneous computed-tomography-guided biopsy of the thoracic and lumbar spine. Spine 16 (1991) 736-739
50. Murphy W.A., Destouet J.M., and Gilula L.A. Percutaneous skeletal biopsy 1981: a procedure for radiologists-results, review, and recommendations. Radiology 139 (1981) 545-549
51. American College of Radiology. Manual on contrast media. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/contrast_manual.aspx Accessed April 10, 2010
52. ®: radiation dose assessment introduction. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/app_criteria/RRLInformation.aspx Accessed April 10, 2010